Bioactive adrenomedullin

There is 1 paper on bioactive adrenomedullin in aging research: 1 observational study in people. The newest story, Oct 4, 2026: “Reduced peptide amidation links to higher Alzheimer's risk”.

Biomarker

1 paper studies it

See all 1 papers on bioactive adrenomedullin

  • Humans1

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 01 paper in 12 months
Alzheimer's Research & Therapy

Reduced peptide amidation links to higher Alzheimer's risk

In 4,543 adults, each standard deviation drop in amidation enzyme activity raised incident Alzheimer's risk with an adjusted hazard ratio of 2.30.In 4,543 adults, each standard deviation drop in amidation enzyme activity raised incident Alzheimer's risk with an adjusted hazard ratio of 2.30.

Cohort study of 4,543 peopleAlzheimer's disease